Tikva is attending the 3rd BioCentury-BayHelix Biopharma Summit 2024: Singapore

Dr. Ivan Horak and Mr. Wilson Cheung will be speaking at the 3rd BioCentury-BayHelix Biopharma Summit 2024: Singapore.

Tikva Allocell Pte Ltd CEO, Ivan Horak and CFO, Wilson Cheung (張偉遜) will be presenting at the 3rd BioCentury-BayHelix East-West Biopharma Summit 2024: Singapore.

For more information on the event, please visit https://conferences.biocentury.com/east-west-summit.

Ivan D. Horak, MD, PhD

Founder & Chief Executive Officer

Wilson W. Cheung

Chief Financial Officer
Share the Post:

Related Posts